Antiepileptic drug adherence in children in southern Ethiopia: A cross sectional study

Shamil Ahmed Dima1, Mulugeta Sitot Shibeshi2

  • 1Department of Pediatrics and Child Health, Madda Walabu University, Gobba, Ethiopia.

Plos One
|February 17, 2022
PubMed

Insights

Treatment adherence is crucial for controlling seizures in children with epilepsy. Low family income and recent seizures were linked to poor antiepileptic drug adherence in a study in Ethiopia.

Area of Science:

  • Pediatric Neurology
  • Public Health
  • Pharmacology

Background:

  • Epilepsy is a common chronic neurological disorder with significant health impacts.
  • Treatment adherence is a key factor in managing seizure control.
  • Understanding factors influencing adherence is vital for effective pediatric epilepsy management.

Purpose of the Study:

  • To identify factors affecting antiepileptic drug (AED) adherence in children with epilepsy.
  • To provide insights for improving treatment adherence in this population.

Main Methods:

  • A cross-sectional study involving 192 children (≤14 years) with epilepsy in Southern Ethiopia.
  • Medication adherence was assessed using the eight-item Morisky's Medication Adherence Scale.
  • Logistic regression analysis was employed to determine factors associated with AED adherence.

Main Results:

  • 65% of children demonstrated adherence to their antiepileptic medications.
  • Factors associated with good adherence included smaller family size (≤5) and shorter epilepsy duration (<2 years).
  • Poor adherence was predicted by lower monthly family income (<1000 ETB) and recent seizure activity (past 3 months).

Conclusions:

  • Antiepileptic drug adherence among children in the study setting is suboptimal.
  • Low family income and recent seizure occurrence are significant predictors of poor adherence.
  • Interventions such as free medication for low-income families and enhanced patient/caretaker education may improve adherence.
Abstract

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
319
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
8
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
111
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
561
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
330
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11